ImmunityBio, Inc. (IBRX)
7.24
+0.07
(+0.98%)
USD |
NASDAQ |
Jun 09, 16:00
7.24
0.00 (0.00%)
After-Hours: 17:32
ImmunityBio Total Liabilities (Quarterly) : 1.516B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Sana Biotechnology, Inc. | 254.35M |
| Erasca, Inc. | 67.71M |
| Arrowhead Pharmaceuticals, Inc. | 1.669B |
| Denali Therapeutics, Inc. | 339.92M |
| Cogent Biosciences, Inc. | 295.31M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 646.64M |
| Shareholders Equity (Quarterly) | -870.01M |
| Debt to Equity Ratio | -1.293 |
| Current Ratio | 6.666 |
| Net Debt Paydown Yield | -0.83% |